| Abstrakt: |
Researchers at Children's Hospital Zagreb have published a report on melasma, a common pigmentary disorder characterized by irregular patches of hyperpigmentation on the face. The condition primarily affects women of reproductive age, especially those with certain skin types. The exact cause of melasma is not fully understood, but factors such as ultraviolet radiation, hormones, and genetics contribute to increased melanin production. Treatment for melasma is challenging due to its multifactorial nature, resistance to therapies, and high recurrence rate. Current treatment options include topical and systemic therapies, procedural interventions, and combinations of these methods. Tailoring treatment to individual patient characteristics is important for optimal results. The researchers emphasize the need for long-term therapy and highlight the latest advancements in managing this condition. [Extracted from the article] |
